Raras
Buscar doenças, sintomas, genes...
Defeito combinado da fosforilação oxidativa QRSL1-relacionado
ORPHA:570491CID-10 · E88.8CID-11 · 5C53.23OMIM 618835DOENÇA RARA

Doença mitocondrial rara caracterizada por início pré-natal ou infantil precoce de cardiomiopatia grave, atraso de crescimento e perturbação global de desenvolvimento, perda auditiva neurossensorial e acidose lática grave. O envolvimento hepático e a insuficiência suprarrenal, assim como a encefalopatia e anomalias de estruturas profundas da substância cinzenta na ressonância magnética cerebral também foram relatados.

Mantido por Agente Raras·Colaborar como especialista →

Introdução

O que você precisa saber de cara

📋

Doença mitocondrial rara caracterizada por início pré-natal ou infantil precoce de cardiomiopatia grave, atraso de crescimento e perturbação global de desenvolvimento, perda auditiva neurossensorial e acidose lática grave. O envolvimento hepático e a insuficiência suprarrenal, assim como a encefalopatia e anomalias de estruturas profundas da substância cinzenta na ressonância magnética cerebral também foram relatados.

Escala de raridade

CLASSIFICAÇÃO ORPHANET · BRASIL 2024
<1 / 1 000 000
Ultra-rara
<1/50k
Muito rara
1/20k
Rara
1/10k
Pouco freq.
1/5k
Incomum
1/2k
Prevalência
0.0
Worldwide
Início
Antenatal
+ infancy, neonatal
🏥
SUS: Sem cobertura SUSScore: 0%
CID-10: E88.8
Você se identifica com essa condição?
O Raras está aqui pra te apoiar — com ou sem diagnóstico

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Entender a doença

Do básico ao detalhe, leia no seu ritmo

Preparando trilha educativa...

Sinais e sintomas

O que aparece no corpo e com que frequência cada sintoma acontece

Partes do corpo afetadas

📏
Crescimento
2 sintomas
🩸
Sangue
1 sintomas
🫃
Digestivo
1 sintomas
❤️
Coração
1 sintomas
👂
Ouvidos
1 sintomas
🛡️
Imunológico
1 sintomas

+ 10 sintomas em outras categorias

Características mais comuns

100%prev.
Acidose láctica
Frequência: 9/9
100%prev.
Anemia
Frequência: 7/7
100%prev.
Cardiomiopatia hipertrófica
Frequência: 9/9
100%prev.
Deficiência auditiva
Obrigatório (100%)
86%prev.
Atividade diminuída do complexo I mitocondrial
Frequência: 6/7
86%prev.
Atividade diminuída do complexo IV mitocondrial
Frequência: 6/7
17sintomas
Muito frequente (6)
Frequente (7)
Ocasional (3)
Sem dados (1)

Os sintomas variam de pessoa para pessoa. Abaixo estão as 17 características clínicas mais associadas, ordenadas por frequência.

Acidose lácticaLactic acidosis
Frequência: 9/9100%
Anemia
Frequência: 7/7100%
Cardiomiopatia hipertróficaHypertrophic cardiomyopathy
Frequência: 9/9100%
Deficiência auditivaHearing impairment
Obrigatório (100%)100%
Atividade diminuída do complexo I mitocondrialDecreased activity of mitochondrial complex I
Frequência: 6/786%

Linha do tempo da pesquisa

Publicações por ano — veja quando o interesse científico cresceu
Anos de pesquisa9
Últimos 10 anos200publicações
Pico202543 papers
Linha do tempo
20202017Hoje · 2026📈 2025Ano de pico
Publicações por ano (últimos 10 anos)

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Genética e causas

O que está alterado no DNA e como passa nas famílias

Genes associados

1 gene identificado com associação a esta condição. Padrão de herança: Autosomal recessive.

QRSL1Glutamyl-tRNA(Gln) amidotransferase subunit A, mitochondrialDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Allows the formation of correctly charged Gln-tRNA(Gln) through the transamidation of misacylated Glu-tRNA(Gln) in the mitochondria. The reaction takes place in the presence of glutamine and ATP through an activated gamma-phospho-Glu-tRNA(Gln)

LOCALIZAÇÃO

Mitochondrion

MECANISMO DE DOENÇA

Combined oxidative phosphorylation deficiency 40

An autosomal recessive mitochondrial disorder characterized by prenatal or infantile onset, fetal hydrops, severe hypertrophic cardiomyopathy, poor growth, sensorineural hearing loss, hepatic dysfunction, lactic acidosis, and decreased activities of mitochondrial respiratory complexes I, III, IV, and V. The disorder is lethal, with death occurring in infancy.

EXPRESSÃO TECIDUAL(Ubíquo)
Linfócitos
17.2 TPM
Baço
12.2 TPM
Nervo tibial
10.9 TPM
Músculo esquelético
10.6 TPM
Fibroblastos
10.5 TPM
OUTRAS DOENÇAS (1)
combined oxidative phosphorylation deficiency 40
HGNC:21020UniProt:Q9H0R6

Variantes genéticas (ClinVar)

35 variantes patogênicas registradas no ClinVar.

🧬 QRSL1: NM_018292.5(QRSL1):c.742del (p.Ala248fs) ()
🧬 QRSL1: NM_018292.5(QRSL1):c.893G>A (p.Trp298Ter) ()
🧬 QRSL1: NM_018292.5(QRSL1):c.1366+2T>G ()
🧬 QRSL1: NM_018292.5(QRSL1):c.45del (p.Gly16fs) ()
🧬 QRSL1: NM_018292.5(QRSL1):c.498del (p.Leu166_Ile167insTer) ()
Ver todas no ClinVar

Diagnóstico

Os sinais que médicos procuram e os exames que confirmam

Carregando...

Tratamento e manejo

Remédios, cuidados de apoio e o que precisa acompanhar

Carregando informações de tratamento...

Onde tratar no SUS

Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)

🇧🇷 Atendimento SUS — Defeito combinado da fosforilação oxidativa QRSL1-relacionado

🗺️

Selecione um estado ou use sua localização para ver resultados.

Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.

Pesquisa ativa

Ensaios clínicos abertos e novidades científicas recentes

Pesquisa e ensaios clínicos

Nenhum ensaio clínico registrado para esta condição.

🧪 Está conduzindo uma pesquisa?
Divulgue para pacientes e familiares que acompanham esta doença.
Divulgar pesquisa →

Publicações mais relevantes

Timeline de publicações
0 papers (10 anos)
#1

Colonic spatial single-cell proteomics and murine models link mitochondrial dysfunction to dimeric IgA-secreting plasma cell deficiency in Crohn's disease.

Nature communications2026 Feb 12

Secretory IgA (SIgA) is critical for maintaining the intestinal barrier. A dysregulated B-cell compartment and altered Ig secretion have been well documented in Crohn's disease (CD) patients, although their origin is unknown. To unravel the role of mucosal humoral immunity in CD pathogenesis, we in-depth phenotype colonic plasma cell (PC) differentiation in CD at the single-cell level, linked to ex vivo functional characterization and experimental mouse models with a congenital mitochondrial defect or under glucose-free high-protein dietary intervention. Here, we demonstrate that despite expanded colonic B cells, CD patients in remission present significantly diminished mucosal dimeric IgA and fecal SIgA. Colonic plasmablasts and immature CD19+CD45+ PCs are increased at the expense of the mature CD19-CD45- phenotype. Accordingly, CD-derived ex vivo differentiated PCs display impaired maturation into dimeric IgA-secreting PCs. In this study, patient-derived data from colonic RNA-seq, spatial single-cell proteomics, and plasma metabolomics are combined with data from both mouse models and highlight the crucial role of mitochondrial oxidative phosphorylation in colonic IgA+-PC differentiation, suggesting promising directions for future therapeutic strategies.

#2

Local mitochondrial physiology defined by mtDNA quality guides purifying selection.

PLoS genetics2026 Jan

The mitochondrial genome (mtDNA) encodes essential subunits of the electron transport chain and ATP synthase. Mutations in these genes impair oxidative phosphorylation, compromise mitochondrial ATP production and cellular energy supply, and can cause mitochondrial diseases. These consequences highlight the importance of mtDNA quality control (mtDNA-QC), the process by which cells selectively maintain intact mtDNA to preserve respiratory function. Here, we developed a high-throughput flow cytometry assay for Saccharomyces cerevisiae to track mtDNA segregation in cell populations derived from heteroplasmic zygotes, in which wild-type (WT) mtDNA is fluorescently labeled and mutant mtDNA remains unlabeled. Using this approach, we observe purifying selection against mtDNA lacking subunits of complex III (COB), complex IV (COX2) or the ATP synthase (ATP6), under fermentative conditions that do not require respiratory activity. By integrating cytometric data with growth assays, qPCR-based mtDNA copy-number measurements, and simulations, we find that the decline of mtDNAΔatp6 in populations derived from heteroplasmic zygotes is largely explained by the combination of its reduced mtDNA copy number-biasing zygotes toward higher contributions of intact mtDNA-and the proliferative disadvantage of cells carrying this variant. In contrast, the loss of mtDNAΔcob and mtDNAΔcox2 cannot be explained by growth defects and copy-number asymmetries alone, indicating an additional intracellular selection against these mutant genomes when intact mtDNA is present. In heteroplasmic cells containing both intact and mutant mtDNA, fluorescent reporters revealed local reductions in ATP levels and membrane potential ([Formula: see text]) near mutant genomes, indicating spatial heterogeneity in mitochondrial physiology that reflects local mtDNA quality. Disruption of the respiratory chain by deletion of nuclear-encoded subunits (RIP1, COX4) abolished these physiological gradients and impaired mtDNA-QC, suggesting that local bioenergetic differences are required for selective recognition. Together, our findings support a model in which yeast cells assess local respiratory function as a proxy for mtDNA integrity, enabling intracellular selection for functional mitochondrial genomes.

#3

Hyperoside impairs mitochondrial respiration in chronic myeloid leukemia by promoting STUB1-mediated ubiquitination and degradation of NOX4.

Toxicology and applied pharmacology2026 Mar 11

Chronic myeloid leukemia (CML) cells exhibit a distinct reliance on oxidative phosphorylation (OXPHOS), presenting a metabolic vulnerability for therapeutic intervention. While Hyperoside, a natural flavonol, demonstrates anti-leukemic activity, its precise molecular targets and impact on mitochondrial bioenergetics remain elusive. In this study, we combined in silico modeling and biophysical validation to identify NADPH oxidase 4 (NOX4) as a direct molecular target of Hyperoside. Surface plasmon resonance and cellular thermal shift assays confirmed high-affinity binding between Hyperoside and NOX4. Hyperoside promotes the proteasomal degradation of NOX4 by enhancing its interaction with the E3 ubiquitin ligase STUB1. This Hyperoside-induced recruitment of STUB1 accelerates NOX4 ubiquitination and turnover in K562 and Meg-01 cells. Functionally, Hyperoside treatment resulted in a severe impairment of mitochondrial respiration, including reduced oxygen consumption rates, diminished ATP production, and inhibitory phosphorylation of the pyruvate dehydrogenase complex. Importantly, these metabolic defects were reversed by NOX4 overexpression or STUB1 knockdown. In summary, our findings characterize a novel STUB1/NOX4 signaling axis and establish Hyperoside as a targeted metabolic modulator that dismantles the bioenergetic machinery essential for CML cell survival.

#4

TAZ (Wwtr1) deficiency leads to ER stress and mitochondrial dysfunction in a mouse model of Fuchs' endothelial corneal dystrophy.

bioRxiv : the preprint server for biology2026 Feb 19

Fuchs' endothelial corneal dystrophy (FECD) impacts over 300 million individuals worldwide with corneal transplantation as the primary treatment. There is a dire need to establish non-surgical alternatives which are dependent on mouse models. Transcriptional co-activator with PDZ-binding motif (TAZ, encoded by Wwtr1) is a mechanotransducer implicated in maintaining homeostasis of corneal endothelial cells (CEnC). Wwtr1 -/- (TAZ KO) mice serve as an animal model for late-onset FECD. We combined single-cell transcriptomics, transmission electron microscopy, and immunofluorescence staining to elucidate the mechanisms driving pathogenesis in young (2-month-old) and geriatric (11-month-old) mice. A progressive stress response was observed in TAZ KOs defined by endoplasmic reticulum (ER) stress, mitochondrial structural and functional abnormalities, and impaired Na+/K+ ATPase localization. These changes were accompanied by an altered expression of genes involved in extracellular matrix (ECM) organization, oxidative phosphorylation, macroautophagy and response to oxidative stress. Additionally, we noted age-related differences in cellular response with young TAZ KO CEnCs upregulating macroautophagy and downregulating ECM organization while geriatric TAZ KO CEnCs downregulated macroautophagy, and ECM organization. Both TAZ KO groups downregulated response to oxidative stress and cell-substrate adhesion. Together, these findings establish a mechanistic link between disrupted mechanotransduction and organelle stress in CEnC degeneration, further elaborating on potential mechanisms driving FECD pathogenesis. This positions TAZ KO mice as a translational platform for evaluating non-surgical therapeutic strategies targeting FECD.

#5

A novel mechanism of chlorogenic acid against type 2 diabetes-induced diabetic retinopathy: suppressing ferroptosis via NRF2/xCT/GPX4 and STAT3 signaling.

Naunyn-Schmiedeberg's archives of pharmacology2026 Feb 23

Diabetic retinopathy (DR) is a common microvascular complication of type 2 diabetes (T2D), driven by hyperglycemia-induced oxidative stress, ferroptosis, and inflammatory signaling. Here, we demonstrate that chlorogenic acid (CGA) ameliorates T2D and DR by simultaneously modulating the NRF2/xCT/GPX4 antioxidant pathway and the p-STAT3/xCT/GPX4 inflammatory-ferroptosis axis. High-fat diet (HFD) combined with streptozotocin (STZ)-induced T2D mice and high-glucose (HG)-stimulated human retinal microvascular endothelial cells (HRMECs) were used to evaluate the effects of CGA in vivo and in vitro. Network pharmacology, molecular docking, Western blotting, immunofluorescence, Seahorse metabolic assays, and site-directed mutagenesis were employed to investigate the underlying molecular mechanisms. CGA treatment significantly improved systemic metabolic parameters, including fasting blood glucose, HbA1c, and insulin sensitivity, while reducing anxiety-like behavior in T2D mice. Histological analyses revealed that CGA alleviated retinal structural abnormalities and decreased lipid droplet accumulation. Mechanistically, CGA activated NRF2/xCT/GPX4 signaling to enhance antioxidant defenses and suppress ferroptosis, while inhibiting STAT3 phosphorylation, reducing pro-inflammatory cytokines, and modulating xCT/GPX4 expression. In HRMECs, NRF2 inhibition or STAT3 activation attenuated CGA's protective effects, highlighting the critical roles of these pathways. Molecular docking and CETSA analyses further identified N485 of STAT3 as a key residue mediating CGA binding and functional regulation. These findings indicate that CGA exerts multi-modal protective effects against DR by targeting oxidative stress, ferroptosis, and inflammation. This study provides mechanistic insight into CGA as a potential therapeutic candidate for T2D-associated retinal complications and underscores the broader relevance of NRF2 and STAT3 pathways as intervention targets in diabetes-related microvascular disorders.

Publicações recentes

Ver todas no PubMed

📚 EuropePMCmostrando 199

2026

Hyperoside impairs mitochondrial respiration in chronic myeloid leukemia by promoting STUB1-mediated ubiquitination and degradation of NOX4.

Toxicology and applied pharmacology
2026

TAZ (Wwtr1) deficiency leads to ER stress and mitochondrial dysfunction in a mouse model of Fuchs' endothelial corneal dystrophy.

bioRxiv : the preprint server for biology
2026

A novel mechanism of chlorogenic acid against type 2 diabetes-induced diabetic retinopathy: suppressing ferroptosis via NRF2/xCT/GPX4 and STAT3 signaling.

Naunyn-Schmiedeberg's archives of pharmacology
2026

Colonic spatial single-cell proteomics and murine models link mitochondrial dysfunction to dimeric IgA-secreting plasma cell deficiency in Crohn's disease.

Nature communications
2026

Optic neuropathy arising from the synergy between YARS2 and mitochondrial COX1 mutations.

Journal of genetics and genomics = Yi chuan xue bao
2025

The metabolic landscape of ovarian cancer stem cells: how do they survive?

Frontiers in oncology
2026

Developmental and metabolic toxicity of diphenyl phosphate: insights from an integrative mechanistic framework in zebrafish embryos.

Environmental pollution (Barking, Essex : 1987)
2026

Local mitochondrial physiology defined by mtDNA quality guides purifying selection.

PLoS genetics
2025

Characterizing the role of mitochondrial dynamics during Drosophila convergent extension using NADH fluorescence lifetime imaging.

bioRxiv : the preprint server for biology
2026

Integrated multi-omics profiling of wooden breast reveals energy metabolism dysfunction and RHOA/ROCK pathway activation.

Food chemistry
2026

Osteoimmunometabolic modulation via hydrogen-self-supplying magnesium-reinforced collagen membrane for enhanced guided bone regeneration.

Biomaterials
2025

Combined ketone body and glutamine supplementation restores aerobic energy production in AGC1-deficient neuronal progenitors.

Cell death &amp; disease
2025

Tumor-agnostic therapy: a potential therapeutic approach for SMARCA4-deficient malignancies.

Therapeutic advances in medical oncology
2025

Exploring the Protective Effects of Two Alkaloids 1 and 2 from Aspergillus terreus C23-3 on Neuronal Cells by Combining Bioinformatics Prediction and Experimental Verification.

ACS chemical neuroscience
2025

β-Nicotinamide mononucleotide activates the SIRT1/NF-κB pathway to alleviate ischemia reperfusion injury after lung transplantation.

Journal of translational medicine
2025

An inherited mitochondrial DNA mutation remodels inflammatory cytokine responses in macrophages and in vivo in mice.

Nature communications
2026

A case of POLG-related mitochondrial DNA maintenance defect.

Acta neurologica Belgica
2025

Gelatin/Graphene Oxide Cryogel as an Artificial Cartilage Substitute Regulates Chondrogenesis and Oxidative Phosphorylation for Osteoarthritis Treatment.

ACS biomaterials science &amp; engineering
2025

Clinical utility of the ATP hydrolysis assay for the diagnosis of complex V deficiency in cultured skin fibroblasts.

Molecular genetics and metabolism
2025

The functional study of novel KLHL3 missense mutations associated with pseudohypoaldosteronism type II.

Endocrine
2025

[Venetoclax resistance and molecular abnormalities in AML].

[Rinsho ketsueki] The Japanese journal of clinical hematology
2025

Exploring the reproductive toxicity and mechanism analysis of perfluorooctanoic acid and perfluorononanoic acid based on network toxicology, molecular docking, and experimental validation.

Environmental toxicology and chemistry
2025

Gene therapy and mRNA drugs approach for mitochondrial OXPHOS deficiencies.

Molecular therapy : the journal of the American Society of Gene Therapy
2025

Defects in anaplerotic metabolism sensitize Staphylococcus aureus small colony variants to bicarbonate.

Microbiology spectrum
2025

Altered Heme and Redox Homeostasis Underpin Late-onset Alzheimer's Disease.

International journal of biological sciences
2025

Assessing a Mitochondrial Disease Treatment via a Novel Statistical Technique for Accelerometer Data.

Annals of clinical and translational neurology
2025

Combined effects of nanoplastics and 3-BHA at environmentally relevant concentrations significantly aggravated kidney injury via TGF-β/SMAD signaling pathway in mice.

Ecotoxicology and environmental safety
2025

Antioxidant functionalized double-net/TA dynamic hydrogel promotes cartilage regeneration through stabilization of chondrocyte phenotype.

Materials today. Bio
2025

Non-invasive visualisation of long-lasting brain metabolic alterations in murine pseudo-infection model using parahydrogen-polarised [1-13C] pyruvate MRI.

Discover nano
2025

Integrating multi-omics and machine learning strategies to explore the "gene-protein-metabolite" network in ischemic heart failure with Qi deficiency and blood stasis syndrome.

Chinese medicine
2025

Bupi Yishen formula improves chronic kidney disease by restoring renal energy metabolism and mitochondrial oxidative phosphorylation.

Phytomedicine : international journal of phytotherapy and phytopharmacology
2025

Microgliosis, neuronal death, minor behavioral abnormalities and reduced endurance performance in alpha-ketoglutarate dehydrogenase complex deficient mice.

Redox biology
2025

OXA1L deficiency causes mitochondrial myopathy via reactive oxygen species regulated nuclear factor kappa B signalling pathway.

Clinical and translational medicine
2025

Targeting the Electron Transport System for Enhanced Longevity.

Biomolecules
2025

Mitochondrial fission factor drives an actionable metabolic vulnerability in multiple myeloma.

Haematologica
2025

Genome sequencing identifies RMND1 as a strong candidate gene for severe prenatal kidney failure mimicking renal tubular dysgenesis associated with hyporeninism.

Pediatric nephrology (Berlin, Germany)
2025

Further delineation of defects in MRPS2 causing human OXPHOS deficiency and early developmental abnormalities in zebrafish.

European journal of human genetics : EJHG
2025

Complex Metabolomic Changes in a Combined Defect of Glycosylation and Oxidative Phosphorylation in a Patient with Pathogenic Variants in PGM1 and NDUFA13.

Cells
2025

Identifying Aberrant 1CM-Related Pathways by Multi-Omics Analysis and Validating Tumor Inhibitory Effect of One-Carbon Donor Betaine in Gastric Cancer.

International journal of molecular sciences
2025

Impairment of Muscle Function Causes Pupal Lethality in Flies Expressing the Mitochondrial Alternative Oxidase.

Biomolecules
2025

Uncovering Mitochondrial Defects Induced by Chemicals: A Case Study of Low-Dose Medium-Chain Chlorinated Paraffin Exposure.

Environmental science &amp; technology
2025

Targeting STING and protecting mitochondrial function with Nephropathy Ⅱ decoction to alleviate renal fibrosis.

Phytomedicine : international journal of phytotherapy and phytopharmacology
2025

Involvement of Oxidative Stress and Antioxidants in Modification of Cardiac Dysfunction Due to Ischemia-Reperfusion Injury.

Antioxidants (Basel, Switzerland)
2025

Atf3 controls transitioning in female mitochondrial cardiomyopathy as identified by spatial and single-cell transcriptomics.

Science advances
2025

Comparative Study of Structural and Functional Rearrangements in Skeletal Muscle Mitochondria of SOD1-G93A Transgenic Mice at Pre-, Early-, and Late-Symptomatic Stages of ALS Progression.

Frontiers in bioscience (Landmark edition)
2025

Endogenous dual-responsive and self-adaptive silk fibroin-based scaffold with enhancement of immunomodulation for skull regeneration.

Biomaterials
2025

A novel polyribonucleotide nucleotidyltransferase 1 (PNPT1) gene variant potentially associated with combined oxidative phosphorylation deficiency 13: case report and literature review.

Translational pediatrics
2025

Divalent metal ions enhance bone regeneration through modulation of nervous systems and metabolic pathways.

Bioactive materials
2025

Clinical and Genetic Insights Into Combined Oxidative Phosphorylation Defect Type 38.

Clinical case reports
2024

Mitochondrial abnormalities as a target of intervention in acute myeloid leukemia.

Frontiers in oncology
2025

Peroxiredoxin 6 maintains mitochondrial homeostasis and promotes tumor progression through ROS/JNK/p38 MAPK signaling pathway in multiple myeloma.

Scientific reports
2024

Multisystem clinicopathologic and genetic analysis of MELAS.

Orphanet journal of rare diseases
2024

Skeletal muscle proteome differs between young APOE3 and APOE4 targeted replacement mice in a sex-dependent manner.

Frontiers in aging neuroscience
2024

RMND1 Mutation Case Report and Literature Review.

Molecular syndromology
2025

Intermittent episodes of acute severe encephalomyopathy and early death in two siblings caused by biallelic likely pathogenic variants in FASTKD2: Expanding phenotype and literature review.

Annals of human genetics
2024

Fusogenic Liposomes for the Intracellular Delivery of Phosphocreatine.

Pharmaceuticals (Basel, Switzerland)
2024

Integrative study of skeletal muscle mitochondrial dysfunction in a murine pancreatic cancer-induced cachexia model.

eLife
2024

[Mitochondrial metabolism in AML cells].

[Rinsho ketsueki] The Japanese journal of clinical hematology
2025

Biallelic PTPMT1 variants disrupt cardiolipin metabolism and lead to a neurodevelopmental syndrome.

Brain : a journal of neurology
2024

SCUBE3 promotes osteogenic differentiation and mitophagy in human bone marrow mesenchymal stem cells through the BMP2/TGF-β signaling pathway.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology
2024

Decoding the muscle transcriptome of patients with late-onset Pompe disease reveals markers of disease progression.

Brain : a journal of neurology
2024

Matrix Protein of Vesicular Stomatitis Virus Targets the Mitochondria, Reprograms Glucose Metabolism, and Sensitizes to 2-Deoxyglucose in Glioblastoma.

Human gene therapy
2024

A roadmap for ribosome assembly in human mitochondria.

Nature structural &amp; molecular biology
2024

Efficacy of Trametinib in Alleviating Cisplatin-Induced Acute Kidney Injury: Inhibition of Inflammation, Oxidative Stress, and Tubular Cell Death in a Mouse Model.

Molecules (Basel, Switzerland)
2024

Relationship between Cellular Oxygen Consumption and Atherosclerosis-Associated Mitochondrial Mutations (Variants of the Mitochondrial Genome).

Current medicinal chemistry
2024

Functional diversity among cardiolipin binding sites on the mitochondrial ADP/ATP carrier.

The EMBO journal
2024

Reduced Protein Import via TIM23 SORT Drives Disease Pathology in TIMM50-Associated Mitochondrial Disease.

Molecular and cellular biology
2024

A zebrafish tufm mutant model for the COXPD4 syndrome of aberrant mitochondrial function.

Journal of genetics and genomics = Yi chuan xue bao
2024

Modulation of Sirtuin 3 by N-Acetylcysteine Preserves Mitochondrial Oxidative Phosphorylation and Restores Bisphenol A-Induced Kidney Damage in High-Fat-Diet-Fed Rats.

Current issues in molecular biology
2024

Evaluating the toxicity of estetrol, 17α-ethinylestradiol, and their combination with drospirenone on zebrafish larvae: A behavioural and proteomic study.

Aquatic toxicology (Amsterdam, Netherlands)
2025

BmATAD3A mediates mitochondrial ribosomal protein expression to maintain the mitochondrial energy metabolism of the silkworm, Bombyx mori.

Insect science
2024

Single cell and bulk RNA expression analyses identify enhanced hexosamine biosynthetic pathway and O-GlcNAcylation in acute myeloid leukemia blasts and stem cells.

Frontiers in immunology
2023

Expanding the Phenotypic Spectrum: Chronic Kidney Disease in a Patient with Combined Oxidative Phosphorylation Defect 21.

Balkan journal of medical genetics : BJMG
2024

Integrating serum pharmacochemistry and network pharmacology to explore the molecular mechanisms of Acanthopanax senticosus (Rupr. & Maxim.) Harms on attenuating doxorubicin-induced myocardial injury.

Journal of ethnopharmacology
2024

Bortezomib in Combination with Physachenolide C Reduces the Tumorigenic Properties of KRASmut/P53mut Lung Cancer Cells by Inhibiting c-FLIP.

Cancers
2023

Expanding the genetic spectrum of mitochondrial diseases in Tunisia: novel variants revealed by whole-exome sequencing.

Frontiers in genetics
2024

A Novel Homozygous Germline Mutation in Transferrin Receptor 1 (TfR1) Leads to Combined Immunodeficiency and Provides New Insights into Iron-Immunity Axis.

Journal of clinical immunology
2024

Association between glaucoma susceptibility with combined defects in mitochondrial oxidative phosphorylation and fatty acid beta oxidation.

Molecular aspects of medicine
2023

The first case of combined oxidative phosphorylation deficiency-1 due to a GFM1 mutation in the Serbian population: a case report and literature review.

The Turkish journal of pediatrics
2023

Challenges in Genetic Diagnosis of Mitochondrial Diseases: What Can Functional Genomics' Studies Do?

Endocrine, metabolic &amp; immune disorders drug targets
2023

Functional Diversity of Mammalian Small Heat Shock Proteins: A Review.

Cells
2023

Huperzine A injection ameliorates motor and cognitive abnormalities via regulating multiple pathways in a murine model of Parkinson's disease.

European journal of pharmacology
2023

Mitochondrial impairment but not peripheral inflammation predicts greater Gulf War illness severity.

Scientific reports
2023

TUFM variants lead to white matter abnormalities mimicking multiple sclerosis.

European journal of neurology
2023

[A case of combined oxidative phosphorylation deficiency 32 caused by MRPS34 gene variation and literature review].

Zhonghua er ke za zhi = Chinese journal of pediatrics
2023

5-Aminolevulinic acid bypasses mitochondrial complex I deficiency and corrects physiological dysfunctions in Drosophila.

Human molecular genetics
2023

A novel biallelic frameshift variant in C2orf69 causing developmental regression, seizures, microcephaly, autistic features, and hypertonia.

American journal of medical genetics. Part A
2024

SESN2-Mediated AKT/GSK-3β/NRF2 Activation to Ameliorate Adriamycin Cardiotoxicity in High-Fat Diet-Induced Obese Mice.

Antioxidants &amp; redox signaling
2023

Severe neonatal onset neuroregression with paroxysmal dystonia and apnoea: Expanding the phenotypic and genotypic spectrum of CARS2-related mitochondrial disease.

JIMD reports
2023

Nono deficiency impedes the proliferation and adhesion of H9c2 cardiomyocytes through Pi3k/Akt signaling pathway.

Scientific reports
2023

Pathogenicity Analysis of a Novel Variant in GTPBP3 Causing Mitochondrial Disease and Systematic Literature Review.

Genes
2023

Anti-AQP4-IgG-positive Leigh syndrome: A case report and review of the literature.

Frontiers in pediatrics
2023

Neuroimaging in mitochondrial disease.

Handbook of clinical neurology
2023

Visualization of mtDNA Using FISH.

Methods in molecular biology (Clifton, N.J.)
2023

Dysregulation of Mitochondrial Translation Caused by CBFB Deficiency Cooperates with Mutant PIK3CA and Is a Vulnerability in Breast Cancer.

Cancer research
2022

Clinical and genetic analyses of premature mitochondrial encephalopathy with epilepsia partialis continua caused by novel biallelic NARS2 mutations.

Frontiers in neuroscience
2023

Predictive plasma biomarker for gestational diabetes: A case-control study in China.

Journal of proteomics
2022

MitoQ alleviates carbon tetrachloride-induced liver fibrosis in mice through regulating JNK/YAP pathway.

Toxicology research
2022

Stimulating Mitochondrial Biogenesis with Deoxyribonucleosides Increases Functional Capacity in ECHS1-Deficient Cells.

International journal of molecular sciences
2022

VARS2 gene mutation leading to overall developmental delay in a child with epilepsy: A case report.

World journal of clinical cases
2024

TARS2 Variants Cause Combination Oxidative Phosphorylation Deficiency-21: A Case Report and Literature Review.

Neuropediatrics
2023

A unique insight for Xiaoyao San exerts antidepressant effects by modulating hippocampal glucose catabolism using stable isotope-resolved metabolomics.

Journal of ethnopharmacology
2022

Exosome-shuttled mitochondrial transcription factor A mRNA promotes the osteogenesis of dental pulp stem cells through mitochondrial oxidative phosphorylation activation.

Cell proliferation
2022

Ferroptosis-related gene signature predicts the clinical outcome in pediatric acute myeloid leukemia patients and refines the 2017 ELN classification system.

Frontiers in molecular biosciences
2022

Functional Restoration of Exhausted CD8 T Cells in Chronic HIV-1 Infection by Targeting Mitochondrial Dysfunction.

Frontiers in immunology
2022

Analysis of Organization and Activity of Mitochondrial Respiratory Chain Complexes in Primary Fibroblasts Using Blue Native PAGE.

Methods in molecular biology (Clifton, N.J.)
2022

Whole exome sequencing identifies a novel compound heterozygous GFM1 variant underlying developmental delay, dystonia, polymicrogyria, and severe intellectual disability in a Pakhtun family.

American journal of medical genetics. Part A
2022

MG53 protein rejuvenates hUC-MSCs and facilitates their therapeutic effects in AD mice by activating Nrf2 signaling pathway.

Redox biology
2022

A Case of Combined Oxidative Phosphorylation Deficiency 35 Associated with a Novel Missense Variant of the TRIT1 Gene.

Molecular syndromology
2022

CRISPR-Cas9 screen identifies oxidative phosphorylation as essential for cancer cell survival at low extracellular pH.

Cell reports
2022

HRAS germline mutations impair LKB1/AMPK signaling and mitochondrial homeostasis in Costello syndrome models.

The Journal of clinical investigation
2022

Novel heterozygous compound TRMT5 mutations associated with combined oxidative phosphorylation deficiency 26 in a Chinese family: a case report.

BMC pediatrics
2022

Combined Treatment with Herbal Medicine and Drug Ameliorates Inflammation and Metabolic Abnormalities in the Liver of an Amyotrophic Lateral Sclerosis Mouse Model.

Antioxidants (Basel, Switzerland)
2022

Clinical and genetic analysis of combined oxidative phosphorylation defificiency-10 caused by MTO1 mutation.

Clinica chimica acta; international journal of clinical chemistry
2022

Genetic diagnosis of basal ganglia disease in childhood.

Developmental medicine and child neurology
2021

Biological significance of MYC and CEBPD coamplification in urothelial carcinoma: Multilayered genomic, transcriptional and posttranscriptional positive feedback loops enhance oncogenic glycolysis.

Clinical and translational medicine
2021

High-intensity training induces non-stoichiometric changes in the mitochondrial proteome of human skeletal muscle without reorganisation of respiratory chain content.

Nature communications
2021

The FASTK family proteins fine-tune mitochondrial RNA processing.

PLoS genetics
2021

Expanding the electro-clinical phenotype of CARS2associated neuroregression.

Epilepsy &amp; behavior reports
2021

Curcumin and Carnosic Acid Cooperate to Inhibit Proliferation and Alter Mitochondrial Function of Metastatic Prostate Cancer Cells.

Antioxidants (Basel, Switzerland)
2021

Development and characterization of a mouse model for Acad9 deficiency.

Molecular genetics and metabolism
2021

Novel Mutations in the GTPBP3 Gene for Mitochondrial Disease and Characteristics of Related Phenotypic Spectrum: The First Three Cases From China.

Frontiers in genetics
2021

APOE genotype dependent molecular abnormalities in the cerebrovasculature of Alzheimer's disease and age-matched non-demented brains.

Molecular brain
2021

Pathogenic variants in MRPL44 cause infantile cardiomyopathy due to a mitochondrial translation defect.

Molecular genetics and metabolism
2021

COXPD9 in an individual from Puerto Rico and literature review.

American journal of medical genetics. Part A
2022

Epigenetic changes related to glucose metabolism in type 1 diabetes after BCG vaccinations: A vital role for KDM2B.

Vaccine
2021

Development of cerebral mitochondrial respiratory function is impaired by thyroid hormone deficiency before birth in a region-specific manner.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology
2021

Mitochondrial metabolism as a target for acute myeloid leukemia treatment.

Cancer &amp; metabolism
2021

Metabolic impact of pathogenic variants in the mitochondrial glutamyl-tRNA synthetase EARS2.

Journal of inherited metabolic disease
2021

Targeting AXL kinase sensitizes leukemic stem and progenitor cells to venetoclax treatment in acute myeloid leukemia.

Blood
2021

The role of mitophagy in the regulation of mitochondrial energetic status in neurons.

Autophagy
2021

Uniparental isodisomy of chromosome 2 causing MRPL44-related multisystem mitochondrial disease.

Molecular biology reports
2021

Energy, Entropy and Quantum Tunneling of Protons and Electrons in Brain Mitochondria: Relation to Mitochondrial Impairment in Aging-Related Human Brain Diseases and Therapeutic Measures.

Biomedicines
2021

Adenylate kinase 2 expression and addiction in T-ALL.

Blood advances
2021

Dysregulation of Metabolic Pathways in Circulating Natural Killer Cells Isolated from Inflammatory Bowel Disease Patients.

Journal of Crohn's &amp; colitis
2020

A novel acceptor stem variant in mitochondrial tRNATyr impairs mitochondrial translation and is associated with a severe phenotype.

Molecular genetics and metabolism
2020

[Analysis of GFM1 gene mutations in a family with combined oxidative phosphorylation deficiency 1].

Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences
2020

Yeast Ppz1 protein phosphatase toxicity involves the alteration of multiple cellular targets.

Scientific reports
2020

The roles of SDHAF2 and dicarboxylate in covalent flavinylation of SDHA, the human complex II flavoprotein.

Proceedings of the National Academy of Sciences of the United States of America
2020

Bioenergetic defects in muscle fibers of RYR1 mutant knock-in mice associated with malignant hyperthermia.

The Journal of biological chemistry
2020

Results of an explorative clinical evaluation suggest immediate and persistent post-reperfusion metabolic paralysis drives kidney ischemia reperfusion injury.

Kidney international
2020

Mitochondria transfer enhances proliferation, migration, and osteogenic differentiation of bone marrow mesenchymal stem cell and promotes bone defect healing.

Stem cell research &amp; therapy
2021

Protein kinase C-δ interacts with and phosphorylates ARD1.

Journal of cellular physiology
2020

Biotin, coenzyme Q10, and their combination ameliorate aluminium chloride-induced Alzheimer's disease via attenuating neuroinflammation and improving brain insulin signaling.

Journal of biochemical and molecular toxicology
2020

TMEM70 functions in the assembly of complexes I and V.

Biochimica et biophysica acta. Bioenergetics
2020

The contribution of ketone bodies to glycolytic inhibition for the treatment of adult and pediatric glioblastoma.

Journal of neuro-oncology
2020

Phenotypes and genotypes of mitochondrial aminoacyl-tRNA synthetase deficiencies from a single neurometabolic clinic.

JIMD reports
2020

Metabolic reprogramming of fibro/adipogenic progenitors facilitates muscle regeneration.

Life science alliance
2020

Hypomorphic variants in AK2 reveal the contribution of mitochondrial function to B-cell activation.

The Journal of allergy and clinical immunology
2019

Inhibition of cAMP/PKA Pathway Protects Optic Nerve Head Astrocytes against Oxidative Stress by Akt/Bax Phosphorylation-Mediated Mfn1/2 Oligomerization.

Oxidative medicine and cellular longevity
2019

Clinical Spectrum and Functional Consequences Associated with Bi-Allelic Pathogenic PNPT1 Variants.

Journal of clinical medicine
2020

Whole-blood transcriptomic responses to lumacaftor/ivacaftor therapy in cystic fibrosis.

Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society
2019

[Mitochondrial DNA deletion syndrome: a case report and literature review].

Lin chuang er bi yan hou tou jing wai ke za zhi = Journal of clinical otorhinolaryngology head and neck surgery
2020

Clinical presentation and proteomic signature of patients with TANGO2 mutations.

Journal of inherited metabolic disease
2019

Novel alanyl-tRNA synthetase 2 (AARS2) homozygous mutation in a consanguineous Chinese family with premature ovarian insufficiency.

Fertility and sterility
2019

Inhibition of hepatocellular carcinoma by metabolic normalization.

PloS one
2019

Alterations of skeletal muscle bioenergetics in a mouse with F508del mutation leading to a cystic fibrosis-like condition.

American journal of physiology. Endocrinology and metabolism
2019

Exophthalmos in Kearns-Sayre syndrome.

Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus
2019

A novel de novo MTOR gain-of-function variant in a patient with Smith-Kingsmore syndrome and Antiphospholipid syndrome.

European journal of human genetics : EJHG
2019

L-Cysteine supplementation prevents liver transplantation in a patient with TRMU deficiency.

Molecular genetics and metabolism reports
2019

Mitochondrial ribosomal protein PTCD3 mutations cause oxidative phosphorylation defects with Leigh syndrome.

Neurogenetics
2018

A predictive algorithm to identify genes that discriminate individuals with fibromyalgia syndrome diagnosis from healthy controls.

Journal of pain research
2018

The Role of Sodium in Diabetic Cardiomyopathy.

Frontiers in physiology
2018

Early-onset Parkinson disease caused by a mutation in CHCHD2 and mitochondrial dysfunction.

Neurology. Genetics
2018

Pathogenic variants in glutamyl-tRNAGln amidotransferase subunits cause a lethal mitochondrial cardiomyopathy disorder.

Nature communications
2018

OXA1L mutations cause mitochondrial encephalopathy and a combined oxidative phosphorylation defect.

EMBO molecular medicine
2018

Clonal expansion of mtDNA deletions: different disease models assessed by digital droplet PCR in single muscle cells.

Scientific reports
2018

Radio-sensitizing effects of VE-821 and beyond: Distinct phosphoproteomic and metabolomic changes after ATR inhibition in irradiated MOLT-4 cells.

PloS one
2018

Mitochondrial DNA transcription and translation: clinical syndromes.

Essays in biochemistry
2018

Combined and individual strategy of exercise generated preconditioning and low dose copper nanoparticles serve as superlative approach to ameliorate ISO-induced myocardial infarction in rats.

Pharmacological reports : PR
2018

Pro-inflammatory cytokines attenuate glucose-stimulated insulin secretion from INS-1E insulinoma cells by restricting mitochondrial pyruvate oxidation capacity - Novel mechanistic insight from real-time analysis of oxidative phosphorylation.

PloS one
2018

Exercise preconditioning and low dose copper nanoparticles exhibits cardioprotection through targeting GSK-3β phosphorylation in ischemia/reperfusion induced myocardial infarction.

Microvascular research
2018

The pathomechanism of cytochrome c oxidase deficiency includes nuclear DNA damage.

Biochimica et biophysica acta. Bioenergetics
2018

High-Resolution FluoRespirometry and OXPHOS Protocols for Human Cells, Permeabilized Fibers from Small Biopsies of Muscle, and Isolated Mitochondria.

Methods in molecular biology (Clifton, N.J.)
2018

Vanishing white matter: a leukodystrophy due to astrocytic dysfunction.

Brain pathology (Zurich, Switzerland)
2018

Intratumoral heterogeneity of oxygen metabolism and neovascularization uncovers 2 survival-relevant subgroups of IDH1 wild-type glioblastoma.

Neuro-oncology
2018

Case report: lactic acidosis and rhabdomyolysis during telbivudine and tenofovir treatment for chronic hepatitis B.

BMC gastroenterology
2018

Brain lactate and pH in schizophrenia and bipolar disorder: a systematic review of findings from magnetic resonance studies.

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology
2018

Bi-allelic Mutations in the Mitochondrial Ribosomal Protein MRPS2 Cause Sensorineural Hearing Loss, Hypoglycemia, and Multiple OXPHOS Complex Deficiencies.

American journal of human genetics
2018

Mitochondrial Encephalopathy: First Portuguese Report of a VARS2 Causative Variant.

JIMD reports
2018

The accumulation of assembly intermediates of the mitochondrial complex I matrix arm is reduced by limiting glucose uptake in a neuronal-like model of MELAS syndrome.

Biochimica et biophysica acta. Molecular basis of disease
2018

Peculiar combinations of individually non-pathogenic missense mitochondrial DNA variants cause low penetrance Leber's hereditary optic neuropathy.

PLoS genetics
2018

Building and decoding ubiquitin chains for mitophagy.

Nature reviews. Molecular cell biology
2018

The genotypic and phenotypic spectrum of MTO1 deficiency.

Molecular genetics and metabolism
2018

Impaired autophagy bridges lysosomal storage disease and epithelial dysfunction in the kidney.

Nature communications
2018

Clinical, biochemical, and genetic features associated with VARS2-related mitochondrial disease.

Human mutation
2018

Pathological mechanisms underlying single large-scale mitochondrial DNA deletions.

Annals of neurology
2018

Impaired mitochondrial respiration in human carotid plaque atherosclerosis: A potential role for Pink1 in vascular smooth muscle cell energetics.

Atherosclerosis
2018

Melanoma tumors exhibit a variable but distinct metabolic signature.

Experimental dermatology
2018

Functional analysis of Toxoplasma lactate dehydrogenases suggests critical roles of lactate fermentation for parasite growth in vivo.

Cellular microbiology
2017

Prevention of doxorubicin-induced cardiomyopathy using targeted MaFGF mediated by nanoparticles combined with ultrasound-targeted MB destruction.

International journal of nanomedicine
2017

Lactate-mediated mitoribosomal defects impair mitochondrial oxidative phosphorylation and promote hepatoma cell invasiveness.

The Journal of biological chemistry
2017

Biallelic C1QBP Mutations Cause Severe Neonatal-, Childhood-, or Later-Onset Cardiomyopathy Associated with Combined Respiratory-Chain Deficiencies.

American journal of human genetics
2017

Molecular and clinical spectra of FBXL4 deficiency.

Human mutation
2018

Tigecycline-induced inhibition of mitochondrial DNA translation may cause lethal mitochondrial dysfunction in humans.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases
2017

Disrupting mitochondrial Ca2+ homeostasis causes tumor-selective TRAIL sensitization through mitochondrial network abnormalities.

International journal of oncology
2018

Retinopathy and optic atrophy: Expanding the phenotypic spectrum of pathogenic variants in the AARS2 gene.

Ophthalmic genetics
2017

Impact of mutations within the [Fe-S] cluster or the lipoic acid biosynthesis pathways on mitochondrial protein expression profiles in fibroblasts from patients.

Molecular genetics and metabolism
2017

Biallelic Mutations in MRPS34 Lead to Instability of the Small Mitoribosomal Subunit and Leigh Syndrome.

American journal of human genetics

Associações

Organizações que acompanham esta doença — pra ter apoio e orientação

Ainda não temos associações cadastradas para Defeito combinado da fosforilação oxidativa QRSL1-relacionado.

É de uma associação que acompanha esta doença? Fale com a gente →

Comunidades

Grupos ativos de quem convive com esta doença aqui no Raras

Ainda não existe comunidade no Raras para Defeito combinado da fosforilação oxidativa QRSL1-relacionado

Pacientes, familiares e cuidadores se organizam em comunidades pra compartilhar experiências, fazer perguntas e se apoiar. Você pode ser o primeiro.

Tire suas dúvidas

Perguntas, dicas e experiências compartilhadas aqui na página

Participe da discussão

Faça login para postar dúvidas, compartilhar experiências e interagir com especialistas.

Fazer login

Doenças relacionadas

Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico

Ordenadas pelo número de sintomas em comum.

Referências e fontes

Bases de dados externas citadas neste artigo

Publicações científicas

Artigos indexados no PubMed ligados a esta doença no grafo RarasNet — título, periódico e PMID direto da fonte, sem intermediação de IA.

  1. Colonic spatial single-cell proteomics and murine models link mitochondrial dysfunction to dimeric IgA-secreting plasma cell deficiency in Crohn's disease.
    Nature communications· 2026· PMID 41680132mais citado
  2. Local mitochondrial physiology defined by mtDNA quality guides purifying selection.
    PLoS genetics· 2026· PMID 41512010mais citado
  3. Hyperoside impairs mitochondrial respiration in chronic myeloid leukemia by promoting STUB1-mediated ubiquitination and degradation of NOX4.
    Toxicology and applied pharmacology· 2026· PMID 41825841mais citado
  4. TAZ (Wwtr1) deficiency leads to ER stress and mitochondrial dysfunction in a mouse model of Fuchs' endothelial corneal dystrophy.
    bioRxiv : the preprint server for biology· 2026· PMID 41756894mais citado
  5. A novel mechanism of chlorogenic acid against type 2 diabetes-induced diabetic retinopathy: suppressing ferroptosis via NRF2/xCT/GPX4 and STAT3 signaling.
    Naunyn-Schmiedeberg's archives of pharmacology· 2026· PMID 41729256mais citado
  6. A case report of combined oxidative phosphorylation deficiency 35 (COXPD35) in Palestine caused by novel compound heterozygous TRIT1 variants.
    Medicine (Baltimore)· 2026· PMID 41760017recente
  7. Anticancer Effect of Pacificusoside D from the Starfish Solaster pacificus in Combination with 2-Deoxy-D-glucose on Oxidative Phosphorylation in Triple-Negative Breast Cancer Cells MDA-MB-231.
    Mar Drugs· 2026· PMID 41745478recente
  8. Protein-induced membrane strain drives supercomplex formation.
    Elife· 2026· PMID 41729568recente
  9. Loss of cystathionine-β-synthase contributes to elevated OXPHOS, a vulnerability in Ara-C-resistant Myeloid Leukemia in Down syndrome.
    Biochem Pharmacol· 2026· PMID 41692349recente
  10. Dynamic balance of myoplasmic energetics, redox state and protons in a fast-twitch oxidative glycolytic skeletal muscle fibre.
    J Physiol· 2026· PMID 41689567recente

Bases de dados e fontes oficiais

Identificadores e referências canônicas usadas para montar este verbete.

  1. ORPHA:570491(Orphanet)
  2. OMIM OMIM:618835(OMIM)
  3. MONDO:0030006(MONDO)
  4. GARD:18006(GARD (NIH))
  5. Variantes catalogadas(ClinVar)
  6. Busca completa no PubMed(PubMed)

Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.

Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar

Compêndio · Raras BR

Defeito combinado da fosforilação oxidativa QRSL1-relacionado

ORPHA:570491 · MONDO:0030006
Prevalência
<1 / 1 000 000
Herança
Autosomal recessive
CID-10
E88.8 · Outros distúrbios especificados do metabolismo
CID-11
Início
Antenatal, Infancy, Neonatal
Prevalência
0.0 (Worldwide)
MedGen
UMLS
C5394232
DiscussaoAtiva

Nenhuma novidade ainda. O agente esta monitorando.

0membros
0novidades